tumor micro-environment
Showing 1 - 25 of >10,000
Colo-rectal Cancer Trial in Beijing (adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro)
Recruiting
- Colo-rectal Cancer
- adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro
-
Beijing, China/Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medici
Aug 4, 2023
Lung Cancer Trial in Shanghai (Biopsy (baseline), Biopsy (optional, after treatment), Biopsy (optional, relapse and metastasis))
Not yet recruiting
- Lung Cancer
- Biopsy (baseline)
- +2 more
-
Shanghai, ChinaShanghai Pulmonary Hospital
May 11, 2023
Colon Cancer, Rectal Cancer, Chemo Effect Trial in Beijing (5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil
Recruiting
- Colon Cancer
- +4 more
- 5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil + formyltetrahydrofolate/Irinotecan + 5-fluorouracil + formyltetrahydrofolate/Cetuximab + 5-fluorouracil + formyltetrahydrofolate
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 15, 2022
Advanced Breast Cancer Trial in Durham (Breast Cancer Tumor Resection)
Recruiting
- Advanced Breast Cancer
- Breast Cancer Tumor Resection
-
Durham, North CarolinaDuke University Medical Center
Jul 13, 2022
Micro and Macroscopic Level of Primary Central Nervous System
Active, not recruiting
- Primary Central Nervous System Lymphoma (PCNSL)
- Tumor samples and MRI
-
Paris, FranceGroupe Hospitalier La Pitié Salpêtrière
Feb 17, 2022
MIRA Clinical Learning Environment (MIRACLE): Lung
Recruiting
- Lung Cancer
- Application of ILD prediction machine learning model to planning imaging
- +5 more
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Jan 9, 2023
Bladder Cancer Trial (urinary micro RNA detection)
Not yet recruiting
- Bladder Cancer
- urinary micro RNA detection
- (no location specified)
Jan 15, 2023
Dexmedetomidine, Perioperative, Electrolyte Trial in Yangzhou (Dexmedetomidine, Normal saline)
Completed
- Dexmedetomidine
- +2 more
- Dexmedetomidine
- Normal saline
-
Yangzhou, Jiangsu, Chinathe Affiliated Hospital of Yangzhou University
Nov 29, 2021
Reactive Hyperemia, Micro RNA, Heart Rate Variability Trial in Copenhagen (Firefighting training exercises with no fire,
Not yet recruiting
- Reactive Hyperemia
- +5 more
- Firefighting training exercises with no fire
- +2 more
-
Copenhagen, DenmarkThe National Research Centre for the Working Environment
Mar 1, 2023
The PEACE Study
Recruiting
- Solid Tumor, Adult
- Cancer
- Tissue Harvest
-
Birmingham, United Kingdom
- +8 more
Feb 22, 2022
MiRNA in Detecting Active Germ Cell Tumors in Early Suspected
Recruiting
- Malignant Testicular Germ Cell Tumor
- Non-Interventional Study
-
Los Angeles, California
- +1 more
Sep 28, 2023
Hepatocellular Cancer Trial in Clichy (IRM with a 5-minute- additional sequence to measure FRM)
Completed
- Hepatocellular Cancer
- IRM with a 5-minute- additional sequence to measure FRM
-
Clichy, FranceValérie Vilgrain
Jun 20, 2022
Malignant Tumor, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Duarte
Recruiting
- Malignant Neoplasm
- +4 more
- Chimeric Antigen Receptor T-Cell Therapy
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 14, 2022
Pituitary Adenoma, Pituitary Tumor, Diabetes Insipidus Cranial Type Trial in Leiden (Micro-electrode measurement)
Recruiting
- Pituitary Adenoma
- +3 more
- Micro-electrode measurement
-
Leiden, NetherlandsLeiden University Medical Center
Apr 13, 2022
MACSSI (MAstectomie Cellules Souches Surveillance Immunitaire)
Recruiting
- Breast Cancer
- Characterization of breast stem & immune system cells infiltrated in the mammary gland
-
Lyon, FranceCentre Léon Bérard
Aug 26, 2022
Patients With IPF
Completed
- Idiopathic Pulmonary Fibrosis
-
Aarhus, DenmarkAarhus University Hospital, Department of Respiratory Diseases a
Aug 9, 2021
Colorectal Adenocarcinoma Trial in Padova (Impact Oral®)
Not yet recruiting
- Colorectal Adenocarcinoma
- Impact Oral®
-
Padova, ItalyIstituto Oncologico Veneto IRCCS
Nov 10, 2023
NSCLC Trial in Goyang-Si (CA and Nivolumab)
Recruiting
- Non-small Cell Lung Cancer
- CA and Nivolumab
-
Goyang-Si, Gyeonggi-do, Korea, Republic ofNational Cancer Center
Apr 4, 2022
Stress Urinary Incontinence Trial in Portland (Retropubic midurethral sling)
Unknown status
- Stress Urinary Incontinence
- Retropubic midurethral sling
-
Portland, Oregon
- +1 more
Sep 14, 2020
Micro-environment Involvement in Muscle Alteration Induced
Completed
- Chronic Obstructive Pulmonary Disease
- +2 more
-
Montpellier, FranceUhmontpellier
Jun 22, 2020
Hilar Cholangiocarcinoma Trial in Xuzhou (I-125 seeds loaded stent (self-expanded metal stent with I-125 seeds, Micro-Tech,
Enrolling by invitation
- Hilar Cholangiocarcinoma
- I-125 seeds loaded stent (self-expanded metal stent with I-125 seeds, Micro-Tech, Nanjing, China)
- Normal stent (self-expanded metal stent without I-125 seeds, Micro-Tech, Nanjing, China)
-
Xuzhou, Jiangsu, ChinaXuzhou Central Hospital
Jul 12, 2021
Metastatic Pancreatic Ductal Adenocarcinoma Trial in Boston, New York (Canakinumab injection; spartalizumab, nab-paclitaxel,
Active, not recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- Canakinumab injection; spartalizumab, nab-paclitaxel, gemcitabine
-
Boston, Massachusetts
- +1 more
Apr 5, 2022
Refractory or Recurrent Solid Tumor Trial in France (Spartalizumab in Pediatric cohort, Low-dose Pazopanib in Pediatric Cohort,
Not yet recruiting
- Refractory or Recurrent Solid Tumor
- Spartalizumab in Pediatric cohort
- +3 more
-
Angers, France
- +8 more
Mar 9, 2022
Clinical Trajectory of Resected Hepatocellular Carcinoma
Completed
- Hepatocellular Carcinoma
-
Kuala Lumpur, Malaysia
- +5 more
Jun 7, 2021
Metastatic Lung Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Rotterdam (Tusamitamab ravtansine)
Not yet recruiting
- Metastatic Lung Cancer
- +2 more
- Tusamitamab ravtansine
-
Rotterdam, NetherlandsErasmus MC
Jan 26, 2023